CLEA Japan Conference Presentation Archive (日本クレア学会発表アーカイブ)：SDT fatty/Jcl
ISN Frontiers 2018 (February 22 - 25): Shinjuku, Tokyo., Japan

2018/02/22

Dapagliflozin Alone or Combined with Ramipril Improves Hyperglycemia, Hypertension, and Prevents Kidney Complications and GFR Decline in the Nephrectomized SDT Fatty Rat Model of Diabetic Nephropathy.

Key Word:
Dapagliflozin（ダパグリフロジン）、Ramipril（ラミプリル）、GFR（クレアチニンクリアランス）、Hyperglycemia（高血糖）、Hypertension（高血圧） obese, type 2 diabetic model（肥満、2型糖尿病モデル）

François Briand¹, Masami Shinohara², Emmanuel Brousseau¹, Takeshi Ohta³, Yasushi Kageyama², Thierry Sulpice¹

¹Physiogenex, Labège, France; ²CLEA Japan Inc. Meguro-ku, Tokyo, Japan, ³Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan

For more details, please click here (Google Search)

SDT fatty Jcl rat イメージ
For the animal model, please click here ▼

If you have any questions, please feel free to contact us.